Zobrazeno 1 - 10
of 66
pro vyhledávání: '"LY2951742"'
Autor:
Mohamed Sayed Zaazouee, Rokaya Y. Ebrahim, Ghaida’a Al-araj, Ibram Zaki, Ahmed Saad, Abdullah Mohamed Farhat, Mustafa Hussein Ali, Mohamed Elshennawy, Omar Khaled Fahmy Fawy, Hadi F. Ahmed, Ziad Alahmad, Eman Ayman Nada, Reem I. Abo-Hamra, Ahmed Bostamy Elsnhory, Mohammed Eleyan, Hazem AbuEl-Enien, Rasha Abdo Elromely, Yossef Hassan AbdelQadir, Jaffer Shah, Alaa Ahmed Elshanbary
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 60, Iss 1, Pp 1-15 (2024)
Abstract Background The humanized monoclonal antibody galcanezumab is an anti-calcitonin-gene-related-peptide (CGRP) and frequently used for migraine prevention. However, the literature revealed limited data with conflicting results. This study aims
Externí odkaz:
https://doaj.org/article/6bfd72377cf642e7a03b4d230493d28f
Publikováno v:
Journal of Pain Research, Vol Volume 13, Pp 1591-1599 (2020)
Lanfranco Pellesi,1 Roberto De Icco,2,3 Mohammad Al-Mahdi Al-Karagholi,1 Messoud Ashina1,4 1Danish Headache Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 2Headache Science Center, IRCCS Mondino Foundat
Externí odkaz:
https://doaj.org/article/e18666c3173b499183da34ea1f549bbc
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 15, Pp 557-569 (2019)
Chiara Lupi,1 Simona Guerzoni,2 Andrea Negro,3 Silvia Benemei1 1Headache Centre, Careggi University Hospital, Department of Health Sciences, University of Florence, Florence, Italy; 2Medical Toxicology Unit, Headache and Drug Abuse Centre, Department
Externí odkaz:
https://doaj.org/article/3cbff400eb5d4f4aa3dfa49096b458fa
Publikováno v:
Patient Preference and Adherence, Vol Volume 12, Pp 1785-1795 (2018)
Virginia L Stauffer,1 Ryan Sides,1 Michel Lanteri-Minet,2,3 William Kielbasa,1 Yan Jin,1 Katherine J Selzler,1 Stewart J Tepper4 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; 2Pain Department, CHU Nice, Nice, France; 3Un
Externí odkaz:
https://doaj.org/article/655d594dde8747eb855e4c709a4e944a
Autor:
Rigmor Jensen, Sheena K. Aurora, Jyun Yan Yang, James M. Martinez, Tina M. Oakes, David W. Dodick, Christian Lucas, Jennifer N. Bardos, Peter J. Goadsby, Chunmei Zhou, Robert R. Conley
Publikováno v:
Cephalalgia
Dodick, D W, Goadsby, P J, Lucas, C, Jensen, R, Bardos, J N, Martinez, J M, Zhou, C, Aurora, S K, Yang, J Y, Conley, R R & Oakes, T 2020, ' Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache : Results from 3-month double-blind treatment ', Cephalalgia, vol. 40, no. 9, pp. 935-948 . https://doi.org/10.1177/0333102420905321
Dodick, D W, Goadsby, P J, Lucas, C, Jensen, R, Bardos, J N, Martinez, J M, Zhou, C, Aurora, S K, Yang, J Y, Conley, R R & Oakes, T 2020, ' Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache : Results from 3-month double-blind treatment ', Cephalalgia, vol. 40, no. 9, pp. 935-948 . https://doi.org/10.1177/0333102420905321
Objective To report efficacy and safety of galcanezumab in adults with chronic cluster headache. Background Galcanezumab is a humanized monoclonal antibody that binds to calcitonin gene-related peptide and inhibits its biological activity. Methods Th
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Margaret B. Ferguson, Qi Zhang, Peter J. Goadsby, David W. Dodick, Vladimir Skljarevski, Tina M. Oakes, James M. Martinez, Sheena K. Aurora
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry
Background and objectiveAs new migraine prevention treatments are developed, the onset of a preventive effect, how long it is maintained and whether patients initially non-responsive develop clinically meaningful responses with continued treatment ca
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Pain Research
The involvement of calcitonin gene-related peptide in migraine and cluster headache has led to the recent development of new therapies. Galcanezumab, a novel monoclonal antibody targeting the calcitonin gene-related peptide, is approved for the migra
Autor:
Antje Tockhorn-Heidenreich, Sriram Govindan, Janet H. Ford, Peter J. Goadsby, Dustin D. Ruff, Virginia L. Stauffer, Sheena K. Aurora, Gisela M Terwindt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b139fc1facd022c0fe3295c64457612d
http://hdl.handle.net/1887/3182717
http://hdl.handle.net/1887/3182717